Reply to "Can the Institute of Medicine review the FDA?".

Nat Med. 2005 Jun; 11(6):589.NMed

Conflict of InterestDrug IndustryNational Academies of Science, Engineering, and Medicine, U.S., Health and Medicine DivisionOrganizational PolicyProduct Surveillance, PostmarketingUnited StatesUnited States Food and Drug Administration